Detalles de la búsqueda
1.
Identification of novel loci for the generation of reporter mice.
Nucleic Acids Res
; 45(6): e37, 2017 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27899606
2.
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease.
Neurobiol Dis
; 114: 74-84, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29486298
3.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.
J Neuroinflammation
; 13(1): 146, 2016 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27295950
4.
Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats.
J Pharmacol Exp Ther
; 356(2): 434-44, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26582732
5.
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates L-DOPA-induced rotational behavior in a rodent model of Parkinson's disease.
J Neurochem
; 134(4): 740-7, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25962878
6.
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells.
Neurobiol Dis
; 82: 235-242, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26094596
7.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.
Neurobiol Dis
; 43(3): 663-8, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21684338
8.
Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: the synergistic role of dopamine.
J Cell Biochem
; 103(3): 877-85, 2008 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17647258
9.
Mitochondrial Complex I Reversible S-Nitrosation Improves Bioenergetics and Is Protective in Parkinson's Disease.
Antioxid Redox Signal
; 28(1): 44-61, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28816057
10.
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.
Front Neurosci
; 11: 306, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28620274
11.
Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.
Stem Cells Transl Med
; 4(9): 1073-85, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26198165
12.
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: comparative study with conventional in vivo techniques in the rat.
J Pharmacol Toxicol Methods
; 70(2): 163-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25117630
13.
Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
Eur J Pharmacol
; 744: 91-7, 2014 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-25446913
14.
Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease.
J Neuropathol Exp Neurol
; 73(5): 414-24, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24709676
15.
Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.
J Mol Neurosci
; 46(1): 177-83, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21671084
16.
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model.
Auton Neurosci
; 169(2): 77-86, 2012 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22608184
17.
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Cell Transplant
; 19(2): 203-17, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19906332
18.
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
Neurobiol Dis
; 29(1): 161-8, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17933546
19.
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
Eur J Neurosci
; 25(2): 397-405, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17284180
20.
Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease.
Neurobiol Dis
; 24(3): 492-505, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17023164